Clinical Performance of the Aptima CMV Quant Assay | Clinical Research Studies Listing

Recruiting

99 years or below

All

20 participants needed

1 Location

Brief description of study

The purpose of this study is to look at the effectiveness of an investigational test called the Aptima CMV Quantification Diagnostic Assay (Aptima CMV Quant Assay) to measure levels of CMV in plasma. The target population is subjects who have tested positive for cytomegalovirus (CMV) after receiving a solid-organ transplant or stem cell transplant. This is a non-interventional study. The main study procedure is the collection of an extra tube of blood when subjects are having routine standard of care CMV testing performed at UPenn.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: CMV
Age: 99 years or below
Gender: All

Updated on 04 Aug 2024. Study ID: 833533

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Clinical Performance of the Aptima CMV Quant Assay on the Panther System

Brief description of study

Eligibility of study

Find a site

Interested in the study